Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluation. (Q54334588)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1990

Language	Label	Description	Also known as
English	Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluation.	scientific article published in January 1990

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

1 reference

based on heuristic

inferred from title

author name string

P B Jensen

1

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

H Roed

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

T Skovsgaard

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

E Friche

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

L Vindeløv

5

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

H H Hansen

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

M Spang-Thomsen

7

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

publication date

1 January 1990

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

27

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

194-198

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic index: a vital component in selection of anticancer agents for clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical pharmacology of VM26 and VP16-213. A brief overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VM 26 and VP 16-213: a comparative analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of three new variant type cell lines derived from small cell carcinoma of the lung.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the P388 murine tumor no longer adequate as a drug discovery model?

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth curves of three human malignant tumors transplanted to nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of an etoposide-resistant human epithelial tumour cell line in vitro: characterization of patterns of cross-resistance and drug sensitivities

1 reference

https://pubmed.ncbi.nlm.nih.gov/2265455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00685712

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/2265455

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54334588&oldid=2212428394"